Vera Therapeutics, Inc.
VERA
$22.57
-$0.04-0.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -102.39% | -86.06% | -58.50% | -30.75% | -0.47% |
| Total Depreciation and Amortization | 686.11% | -66.73% | 400.00% | 109.31% | 104.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 124.50% | 90.91% | 53.01% | 19.33% | -30.78% |
| Change in Net Operating Assets | 196.08% | 111.89% | 145.69% | -72.58% | -202.45% |
| Cash from Operations | -73.59% | -55.69% | -46.10% | -36.78% | -27.60% |
| Capital Expenditure | -740.79% | -1,739.68% | -1,442.86% | -- | -300.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.38% | 30.13% | -977.16% | -314.59% | -227.68% |
| Cash from Investing | 32.81% | 29.72% | -977.91% | -315.47% | -227.72% |
| Total Debt Issued | -5.67% | -- | -- | 24.85% | 24.85% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17.38% | 19.58% | 456.55% | 155.74% | 153.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -39.18% | -19.50% | -440.61% | -148.59% | -146.26% |
| Cash from Financing | 14.23% | 9.79% | 354.30% | 136.09% | 134.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 373.01% | 79.56% | 2,334.68% | 94.44% | 47.69% |